The relationship between smoking cessation history and significant liver fibrosis among the population with metabolic dysfunction-associated steatotic liver disease in the United States
This study revealed that individuals with MASLD who have ceased smoking exhibit an elevated risk for significant liver fibrosis when compared to those who never smoked. It is highly emphasized that MASLD patients who quit smoking for < 20 years, started regularly smoking at an age of ≤ 20 years, and had a smoking duration of ≥ 10 years before quitting should be extremely vigilant regarding the risk of significant liver fibrosis.
Authors
- Haochun Guo (ORCID: https://orcid.org/0000-0002-6742-6634)
- Shu Wang (ORCID: https://orcid.org/0000-0002-1109-2073)
- Zhongtao Li (ORCID: https://orcid.org/0000-0003-3804-8256)
- Hongyu He (ORCID: https://orcid.org/0000-0002-4034-3812)
- Xie Liang (ORCID: https://orcid.org/0000-0002-7957-364X)
- Shufen Pei
Institutions
- North Sichuan Medical University (CN)
- Affiliated Hospital of North Sichuan Medical College (CN)
- Lanzhou University Second Hospital (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1371/journal.pone.0320573
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71